Prevention of Atopic Dermatitis in High‐Risk Infants: A Review of the Role of Lipid‐Based Barrier Repair Therapy
Pediatric Dermatology · 2025
DOI: 10.1111/pde.70010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pediatric Dermatology, 2025. Verfasst von Chon-Wai Jeremy Chan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, John Hunter Hospital, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Lipids. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background/Objective Growing evidence highlights the role of physiological lipids, namely ceramides, cholesterol, and free fatty acids, in maintaining skin barrier function and preventing atopic dermatitis (AD). Current evidence on the efficacy, safety, and clinical relevance of stratum corneum (SC) lipid‐based therapies to prevent AD and increase skin barrier integrity in high‐risk infants was reviewed and synthesized.
Methods
Searches with key words lipid‐based therapy, atopic dermatitis, infant, and prevention were conducted to identify papers using PubMed, Embase, Cochrane Library, and Scopus databases from January 2000 to June 2024.
Results
SC lipid‐based therapies were reported to replenish deficient SC lipids, thereby improving skin barrier function, a critical aspect of AD management. These therapies reduced SCORAD scores, enhanced hydration, and improved epidermal cohesion, with some studies reporting comparable efficacy to topical corticosteroids when used as adjunct treatments. However, evidence supporting their effectiveness in preventing AD onset in infants remains limited, with only trends toward reduced AD incidence and food sensitization reported, without statistical significance. Importantly, SC lipid therapies are well tolerated, with no significant adverse effects noted, supporting their safety in infants and children.
Conclusion
This review ascertained knowledge gaps that can direct research and resolve controversies regarding emollients. Mechanistic studies in high‐risk and non‐atopic infants, starting at birth, are warranted using within‐subject comparisons and frequent evaluations, including SC sampling for proteomics and lipidomics outcomes for mechanistic insight. Studies should begin with relatively simple formulations, for example, containing only ceramides, cholesterol, and fatty acids matched to varying infant SC lipid profiles at birth and over time.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, John Hunter Hospital, Sydney, New South Wales, Australia.
- School of Medicine and Public Health, University of Newcastle, Sydney, New South Wales, Australia.
- James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio, USA.
ORCID-Profile: Chon-Wai Jeremy Chan, Marty O Visscher
Zitieren
APA
Chan, C. J., & Visscher, M. O. (2025). Prevention of Atopic Dermatitis in High‐Risk Infants: A Review of the Role of Lipid‐Based Barrier Repair Therapy. Pediatric Dermatology. https://doi.org/10.1111/pde.70010
Vancouver
Chan CJ, Visscher MO. Prevention of Atopic Dermatitis in High‐Risk Infants: A Review of the Role of Lipid‐Based Barrier Repair Therapy. Pediatric Dermatology. 2025. doi:10.1111/pde.70010
BibTeX
@article{Chan2025,
author = {Chan, Chon-Wai Jeremy and Visscher, Marty O},
title = {Prevention of Atopic Dermatitis in High‐Risk Infants: A Review of the Role of Lipid‐Based Barrier Repair Therapy},
journal = {Pediatric Dermatology},
year = {2025},
doi = {10.1111/pde.70010}
}
EUVIMED